Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11

Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Exact query	Computed	Source
All time	… → 2026-09-15	("Acute Myeloid Leukemia with inv 16 p13.1q22 or t 16 16 p13.1 q22 CBFB-MYH11"[tiab] OR "Acute Myeloid Leukemia, CBFB-MYH11"[tiab] OR "Acute Myeloid Leukemia, CBF-beta/MYH11"[tiab] OR "Acute Myeloid Leukemia with CBFB-MYH11 Fusion"[tiab] OR "Acute Myeloid Leukemia with Abnormal Marrow Eosinophils"[tiab] OR "AML with inv 16 p13.1q22 or t 16 16 p13.1 q22 CBFB-MYH11"[tiab] OR "AML with inv 16 p13q22 or t 16 16 p13.1 q22 , CBFB/MYH11"[tiab] OR "Acute Myeloid Leukemia With Inv 16 p13.1q22 Or T 16 16 p13.1 q22"[tiab])	2026-09-15	pubmed
Last 5 years	2021-01-01 → 2026-12-31	("Acute Myeloid Leukemia with inv 16 p13.1q22 or t 16 16 p13.1 q22 CBFB-MYH11"[tiab] OR "Acute Myeloid Leukemia, CBFB-MYH11"[tiab] OR "Acute Myeloid Leukemia, CBF-beta/MYH11"[tiab] OR "Acute Myeloid Leukemia with CBFB-MYH11 Fusion"[tiab] OR "Acute Myeloid Leukemia with Abnormal Marrow Eosinophils"[tiab] OR "AML with inv 16 p13.1q22 or t 16 16 p13.1 q22 CBFB-MYH11"[tiab] OR "AML with inv 16 p13q22 or t 16 16 p13.1 q22 , CBFB/MYH11"[tiab] OR "Acute Myeloid Leukemia With Inv 16 p13.1q22 Or T 16 16 p13.1 q22"[tiab]) AND (2021/01/01:2026/12/31[dp])	2026-09-15	pubmed
Last 12 months	2025-09-15 → 2026-09-15	("Acute Myeloid Leukemia with inv 16 p13.1q22 or t 16 16 p13.1 q22 CBFB-MYH11"[tiab] OR "Acute Myeloid Leukemia, CBFB-MYH11"[tiab] OR "Acute Myeloid Leukemia, CBF-beta/MYH11"[tiab] OR "Acute Myeloid Leukemia with CBFB-MYH11 Fusion"[tiab] OR "Acute Myeloid Leukemia with Abnormal Marrow Eosinophils"[tiab] OR "AML with inv 16 p13.1q22 or t 16 16 p13.1 q22 CBFB-MYH11"[tiab] OR "AML with inv 16 p13q22 or t 16 16 p13.1 q22 , CBFB/MYH11"[tiab] OR "Acute Myeloid Leukemia With Inv 16 p13.1q22 Or T 16 16 p13.1 q22"[tiab]) AND (2025/09/15:2026/09/15[dp])	2026-09-15	pubmed

Data updated 16 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (3)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–3 of 3 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
· J Clin Oncol · 2005 · PMID 16110030 · validated civic_curation pubmed
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.
· J Clin Oncol · 2004 · PMID 15289486 · validated civic_curation pubmed
Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association.
· N Engl J Med · 1983 · PMID 6577285 · validated civic_curation pubmed